0.916
Precedente Chiudi:
$0.9225
Aprire:
$0.902
Volume 24 ore:
2,016
Relative Volume:
0.06
Capitalizzazione di mercato:
$38.73M
Reddito:
$13.42M
Utile/perdita netta:
$-73.35M
Rapporto P/E:
-0.4771
EPS:
-1.92
Flusso di cassa netto:
$-56.34M
1 W Prestazione:
+8.91%
1M Prestazione:
+10.36%
6M Prestazione:
-13.58%
1 anno Prestazione:
-33.86%
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile
Nome
Barinthus Biotherapeutics Plc Adr
Settore
Industria
Telefono
44 (0) 1865 818808
Indirizzo
UNIT 6-10, ZEUS BUILDING, DIDCOT
Confronta BRNS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
BRNS
Barinthus Biotherapeutics Plc Adr
|
0.916 | 38.73M | 13.42M | -73.35M | -56.34M | -1.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-05-25 | Iniziato | Jefferies | Buy |
2021-05-25 | Iniziato | Morgan Stanley | Overweight |
2021-05-25 | Iniziato | William Blair | Outperform |
2021-05-24 | Iniziato | H.C. Wainwright | Buy |
Barinthus Biotherapeutics Plc Adr Borsa (BRNS) Ultime notizie
BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com UK
Dollar General Corp (DG) Shares Up Despite Recent Market Volatility - The News Heater
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - MSN
Exclusive-Mexico's Pemex, billionaire Slim renegotiate deepwater gas project - Yahoo Finance
RBC raises Reckitt Benckiser stock target to £57.00, keeps outperform - MSN
Stocks Generating Improved Relative Strength: Revolution Medicines - MSN
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice
Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer
Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Barinthus Biotherapeutics Plc Adr Azioni (BRNS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):